In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘chemotherapy’ clear

  • In a recent national study led by Dr. Jane Weeks, 69 percent of those with stage 4 lung cancer and 81 percent of those with stage 4 colon cancer failed to understand that chemotherapy was not at all likely to cure their cancer.

Tags: chemotherapy, EndOfLife

  • Dr. David Frank, who says that tracking drug pedigree is paramount in determining its authenticity, explained how Dana-Farber checks the provenance of all drugs its caregivers use.

Tags: chemotherapy, PatientSafety

  • A study by researchers at Dana-Farber shows many patients with advanced cancers put false hope in chemotherapy. The study, published in the New England Journal of Medicine, found 69 percent of patients with lung cancer and 81 percent of those with colorectal cancer did not report understanding chemotherapy was not likely to cure their cancer.

Tags: chemotherapy, BasicResearch, EndOfLife

  • Dr. Sidney Farber – as featured in the PBS film “Cancer: The Emperor of All Maladies” – was described as an unsung hero of cancer research for his efforts in discovering the use of chemotherapy as a form of treatment for pediatric cancer patients.

Tags: chemotherapy, ChildhoodCancer, JimmyFund

  • Dr. Alexi Wright led a study that found patients with terminal cancer who fight to the very end, taking debilitating chemotherapy treatments in the last months of life, often end up dying in intensive care.

Tags: chemotherapy, EndOfLife, CopingWithCancer

  • Dr. Matthew Kulke writes that the diagnosis and treatment of advanced pancreatic neuroendocrine tumors have recently been boosted by a number of clinical developments. In the past year, two drugs have been approved for these obscure long-neglected tumors. (Subscription needed to view this article)

Tags: chemotherapy, PancreaticCancer

  • A pair of studies showed a new type of anti-cancer drug, which works in an entirely different way from chemotherapy. Dr. George Demetri says the field is moving toward using the right drugs at the right time in the right patients.

Tags: chemotherapy, BasicResearch

  • A new study conducted by scientists from Dana-Farber Cancer Institute and Karolinska Institutet in Sweden, presents very promising results for the treatment of multiple myeloma.

Tags: chemotherapy, MultipleMyeloma

  • Dr. James Butrynski says for the majority of patients being treated with Doxil, changing treatment is a challenge because there's a risk that another medication won't be as successful. Sylvia Bartel, RPh, said that Dana-Farber has dedicated a full-time member of the pharmacy staff to monitor drug supplies, something she says they have never had to worry about until recently.

Tags: chemotherapy, PatientSupport

  • Sylvia Bartel, RPh, says the current drug shortages, especially for drugs that have been around for some years, is likely tied to the economics around generic drugs.

Tags: chemotherapy, PatientSupport

Showing 1-10 of 17 items